131 related articles for article (PubMed ID: 19521888)
1. Effect of olmesartan medoxomil on cystatin C level, left ventricular hypertrophy and diastolic function.
Albayrak S; Ordu S; Ozhan H; Yazici M; Aydin M; Alemdar R; Kaya A
Blood Press; 2009; 18(4):187-91. PubMed ID: 19521888
[TBL] [Abstract][Full Text] [Related]
2. Effect of Olmesartan on serum cystatin C levels in the patients with essential hypertension.
Koc Y; Mazi E; Sakaci T; Basturk T; Damar AB; Ahbap E; Unsal A; Borlu F
Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1389-94. PubMed ID: 22288300
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of olmesartan therapy on fibrinolytic capacity in patients with hypertension.
Bulur S; Ozhan H; Erden I; Alemdar R; Aydin M; Caglar O; Basar C; Ordu S
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):29-33. PubMed ID: 20975532
[TBL] [Abstract][Full Text] [Related]
4. Comparison of olmesartan medoxomil versus amlodipine besylate on regression of ventricular and vascular hypertrophy.
Rosendorff C; Dubiel R; Xu J; Chavanu KJ
Am J Cardiol; 2009 Aug; 104(3):359-65. PubMed ID: 19616668
[TBL] [Abstract][Full Text] [Related]
5. Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
Mallion JM; Heagerty A; Laeis P
J Hypertens; 2007 Oct; 25(10):2168-77. PubMed ID: 17885562
[TBL] [Abstract][Full Text] [Related]
6. Effect of an olmesartan medoxomil-based treatment algorithm on systolic blood pressure in patients with stage 1 or 2 hypertension: a randomized, double-blind, placebo-controlled study.
Kereiakes DJ; Maa JF; Shojaee A; Dubiel R
Am J Cardiovasc Drugs; 2010; 10(4):239-46. PubMed ID: 20653330
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial study.
Chrysant SG; Chavanu KJ; Xu J
Am J Cardiovasc Drugs; 2009; 9(4):241-51. PubMed ID: 19655819
[TBL] [Abstract][Full Text] [Related]
8. Effects of olmesartan medoxomil, an angiotensin II type 1 receptor antagonist, on plasma concentration of B-type natriuretic peptide, in hypertensive patients with type 2 diabetes mellitus: a preliminary, observational, open-label study.
Kawai T; Takei I; Shimada A; Hirata T; Tanaka K; Saisho Y; Irie J; Horimai C; Matsumoto H; Itoh H
Clin Drug Investig; 2011; 31(4):237-45. PubMed ID: 21184621
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension.
Tsutamoto T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
Hypertens Res; 2010 Feb; 33(2):118-22. PubMed ID: 19927151
[TBL] [Abstract][Full Text] [Related]
10. Possible beneficial effect of olmesartan medoxomil on left atrial function in patients with hypertension : noninvasive assessment by acoustic quantification.
Gong HP; Zhang W; Li L; Tan HW; Ma ZY; Zhong XZ; Wang ZH; Song T; Zhang Y; Zhong M
Clin Drug Investig; 2008; 28(4):241-9. PubMed ID: 18345714
[TBL] [Abstract][Full Text] [Related]
11. Olmesartan medoxomil reverses left ventricle hypertrophy and reduces inflammatory cytokine IL-6 in the renovascular hypertensive rats.
Li ZC; Yu HY; Wang XX; Zhang M; Wang JP
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3318-22. PubMed ID: 24379062
[TBL] [Abstract][Full Text] [Related]
12. Use of 24-h ambulatory blood pressure monitoring to assess blood pressure control: a comparison of olmesartan medoxomil and amlodipine besylate.
Chrysant SG; Marbury TC; Silfani TN
Blood Press Monit; 2006 Jun; 11(3):135-41. PubMed ID: 16702822
[TBL] [Abstract][Full Text] [Related]
13. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation.
Fliser D; Buchholz K; Haller H;
Circulation; 2004 Aug; 110(9):1103-7. PubMed ID: 15313950
[TBL] [Abstract][Full Text] [Related]
14. Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor.
Hasler C; Nussberger J; Maillard M; Forclaz A; Brunner HR; Burnier M
Clin Pharmacol Ther; 2005 Nov; 78(5):501-7. PubMed ID: 16321616
[TBL] [Abstract][Full Text] [Related]
15. Valsartan reduces serum cystatin C and the renal vascular resistance in patients with essential hypertension.
Watanabe S; Okura T; Kurata M; Irita J; Manabe S; Miyoshi K; Fukuoka T; Gotoh A; Uchida K; Higaki J
Clin Exp Hypertens; 2006 Jul; 28(5):451-61. PubMed ID: 16820342
[TBL] [Abstract][Full Text] [Related]
16. Olmesartan ameliorates myocardial function independent of blood pressure control in patients with mild-to-moderate hypertension.
Futai R; Ito T; Kawanishi Y; Terasaki F; Kitaura Y
Heart Vessels; 2009 Jul; 24(4):294-300. PubMed ID: 19626403
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.
Chrysant SG; Marbury TC; Robinson TD
J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension.
Smolensky MH; Hermida RC; Portaluppi F
Chronobiol Int; 2007; 24(1):171-81. PubMed ID: 17364587
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide.
Chrysant SG; Weber MA; Wang AC; Hinman DJ
Am J Hypertens; 2004 Mar; 17(3):252-9. PubMed ID: 15001200
[TBL] [Abstract][Full Text] [Related]
20. Inverse association of estimated cystatin C- and creatinine-based glomerular filtration rate with left ventricular mass: Results from the Study of Health in Pomerania.
Aumann N; Baumeister SE; Werner A; Wallaschofski H; Hannemann A; Nauck M; Rettig R; Felix SB; Dörr M; Völzke H; Lieb W; Stracke S
Int J Cardiol; 2013 Sep; 167(6):2786-91. PubMed ID: 22884092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
